These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20558849)

  • 1. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities.
    Rosenblatt A; Gao J; Mackell J; Richardson S
    Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.
    Tariot P; Salloway S; Yardley J; Mackell J; Moline M
    BMC Res Notes; 2012 Jun; 5():283. PubMed ID: 22681723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, open-label, 24-week follow-up study for efficacy on cognitive function of donepezil in Binswanger-type subcortical vascular dementia.
    Kwon JC; Kim EG; Kim JW; Kwon OD; Yoo BG; Yi HA; Choi NC; Ahn SY; Lee BH; Kang MJ; Choi DS;
    Am J Alzheimers Dis Other Demen; 2009; 24(4):293-301. PubMed ID: 19383979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S; Feldman H; Hecker J; Vellas B; Emir B; Subbiah P;
    Curr Med Res Opin; 2002; 18(6):347-54. PubMed ID: 12442882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR; Salloway S; Tariot PN; Yardley J; Moline ML; Wang Q; Brand-Schieber E; Zou H; Hsu T; Satlin A
    Clin Ther; 2010 Jul; 32(7):1234-51. PubMed ID: 20678673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer's disease: a 20-week open-label pilot study.
    Li DQ; Zhou YP; Yang H
    Int J Med Sci; 2012; 9(3):248-55. PubMed ID: 22606044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.
    Holmes C; Wilkinson D; Dean C; Vethanayagam S; Olivieri S; Langley A; Pandita-Gunawardena ND; Hogg F; Clare C; Damms J
    Neurology; 2004 Jul; 63(2):214-9. PubMed ID: 15277611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
    Doody RS; Corey-Bloom J; Zhang R; Li H; Ieni J; Schindler R
    Drugs Aging; 2008; 25(2):163-74. PubMed ID: 18257603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil therapy in clinical practice: a randomized crossover study.
    Greenberg SM; Tennis MK; Brown LB; Gomez-Isla T; Hayden DL; Schoenfeld DA; Walsh KL; Corwin C; Daffner KR; Friedman P; Meadows ME; Sperling RA; Growdon JH
    Arch Neurol; 2000 Jan; 57(1):94-9. PubMed ID: 10634454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study.
    Schmitt FA; Saxton J; Ferris SH; Mackell J; Sun Y
    Int J Clin Pract; 2013 Oct; 67(10):1050-6. PubMed ID: 24073978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.